{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:00:32Z","timestamp":1791046832658,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.dld.2004.04.006","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T19:35:45Z","timestamp":1089142545000},"page":"622-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases"],"prefix":"10.1016","volume":"36","author":[{"given":"M","family":"Enjoji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nakamuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2004.04.006_BIB1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1501::AID-CNCR12>3.0.CO;2-3","article-title":"A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas","volume":"77","author":"Sonoda","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2004.04.006_BIB2","first-page":"1517","article-title":"Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias","volume":"4","author":"Sonoda","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.dld.2004.04.006_BIB3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/11383","article-title":"Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1","volume":"5","author":"Nakashima","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.dld.2004.04.006_BIB4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/1097-0215(20001120)89:6<488::AID-IJC4>3.0.CO;2-D","article-title":"Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1","volume":"89","author":"Iwasaki","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.dld.2004.04.006_BIB5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/1097-0142(20010715)92:2<446::AID-CNCR1341>3.0.CO;2-3","article-title":"Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma","volume":"92","author":"Izumi","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2004.04.006_BIB6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(00)00170-5","article-title":"RCAS1 antigen is highly expressed in extramammary Paget\u2019s disease and in advanced stage squamous cell carcinoma of the skin","volume":"26","author":"Takahashi","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.dld.2004.04.006_BIB7","first-page":"695","article-title":"Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer","volume":"19","author":"Kubokawa","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.dld.2004.04.006_BIB8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0304-3835(01)00541-9","article-title":"Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma","volume":"168","author":"Noguchi","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.dld.2004.04.006_BIB9","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1054\/bjoc.2001.2176","article-title":"EBAG9\/RCAS1 in human breast carcinoma: a possible factor in endocrine\u2013immune interactions","volume":"85","author":"Suzuki","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.dld.2004.04.006_BIB10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/modpathol.3880467","article-title":"Immunohistochemical analysis of RCAS1 in human pituitary adenomas","volume":"14","author":"Umeoka","year":"2001","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.dld.2004.04.006_BIB11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3835(01)00773-X","article-title":"The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus","volume":"177","author":"Nakakubo","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.dld.2004.04.006_BIB12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.10381","article-title":"High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker","volume":"99","author":"Hiraoka","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.dld.2004.04.006_BIB13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0168-8278(02)00066-1","article-title":"The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of the biliary tract","volume":"36","author":"Enjoji","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.dld.2004.04.006_BIB14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00004836-200203000-00023","article-title":"RCAS1 expression in immune-mediated liver diseases","volume":"34","author":"Enjoji","year":"2002","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.dld.2004.04.006_BIB15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0168-8278(03)00363-5","article-title":"Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma","volume":"39","author":"Watanabe","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.dld.2004.04.006_BIB16","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2362.1992.tb01449.x","article-title":"Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumor markers in benign and malignant diseases","volume":"22","author":"Basso","year":"1992","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.dld.2004.04.006_BIB17","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/1097-0142(19880515)61:10<2100::AID-CNCR2820611028>3.0.CO;2-Z","article-title":"CA19-9 and CA50 in benign and malignant pancreatic and biliary diseases","volume":"61","author":"Paganuzzi","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2004.04.006_BIB18","first-page":"350","article-title":"The clinical utility of the CA19-9 tumor-associated antigen","volume":"85","author":"Steinberg","year":"1990","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2004.04.006_BIB19","first-page":"539","article-title":"CA19-9 estimation in the assessment of pancreatic or biliary tract malignancy\u2014what is the most efficient threshold value?","volume":"3","author":"Welfare","year":"1991","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.dld.2004.04.006_BIB20","first-page":"616","article-title":"The assessment of biliary CA125, CA19-9 and CEA in diagnosing cholangiocarcinoma\u2014the influence of sampling tome and hepatolithiasis","volume":"49","author":"Chen","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.dld.2004.04.006_BIB21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1440-1746.1991.tb00896.x","article-title":"Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma","volume":"6","author":"Ker","year":"1991","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865804002142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865804002142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:07:45Z","timestamp":1761624465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865804002142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1590865804002142"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2004.04.006","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2004.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}